22 Participants Needed

Supervised Exercise for Depression in HIV

SL
SL
Overseen BySarah Lofgren, MD
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: University of Minnesota
Must be taking: Antiretrovirals

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your healthcare provider.

What data supports the effectiveness of the treatment Supervised Treadmill Intervention, Exercise Therapy, Physical Activity Intervention, Treadmill Exercise for depression in HIV?

Research shows that aerobic exercise, like treadmill workouts, can help reduce depressive symptoms in people living with HIV. A study found that HIV-infected adults who participated in a supervised aerobic exercise program reported fewer symptoms of depression compared to those who did not exercise.12345

Is supervised exercise safe for people living with HIV?

Supervised exercise, including aerobic and resistance training, has been shown to be safe for people living with HIV. Studies indicate that exercise does not harm immune function and can improve fitness, muscle strength, and quality of life without adverse effects.12678

How does the Supervised Treadmill Intervention treatment for depression in HIV differ from other treatments?

The Supervised Treadmill Intervention is unique because it uses structured exercise, specifically treadmill walking, to help reduce depression in people living with HIV. Unlike medications, this treatment focuses on physical activity, which can improve mood and overall well-being without the side effects associated with drugs.12579

What is the purpose of this trial?

Depression in people living with HIV is associated with worse care engagement, drug adherence, and higher rates of pre-mature mortality. The prevalence of depression is three times greater in those with HIV than comparable controls. While antiretroviral therapy (ART) enables immune reconstitution, those with depression do worse clinically than those without depression even when controlling for HIV stage. However, treating depression in HIV-infected persons is challenging. Even among those virologically suppressed on ART, a significant percentage are resistant to standard pharmacotherapy or psychotherapy for depression. The reasons for this are complex and poorly understood. An emerging body of evidence indicates that inflammation may perpetuate depression. Given people with HIV have ongoing increased inflammation, this could help explain part of why depression rates are so high in people with HIV.Treatments for HIV-associated depression would likely be more effective if they were anti- inflammatory in nature. One possible treatment is exercise. Exercise is acutely pro-inflammatory due to catabolism but in the long term is anti-inflammatory. However, few studies have investigated exercise as a treatment for HIV-associated depression. The study objective is to perform a feasibility study to evaluate a larger trial evaluating the efficacy of exercise as an intervention for depression in people with HIV.

Research Team

SL

Sarah Lofgren, PhD

Principal Investigator

University of Minnesota

AA

Anita Arinda, PhD

Principal Investigator

University of Minnesota

RM

Ryan Mays, PhD

Principal Investigator

University of Minnesota

Eligibility Criteria

This trial is for adults aged 18-45 with HIV, who are not currently in a formal exercise program or doing manual labor. They must be receiving HIV therapy and have their virus under control (less than 400 copies/mL). Participants should also have mild to moderate depression but not severe enough to score over 20 on the PHQ9 scale.

Inclusion Criteria

You are not currently doing regular exercise or physically demanding work like construction or delivery.
You are currently receiving care at the Mildmay HIV clinic.
You have HIV.
See 5 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in a supervised treadmill exercise intervention to evaluate its efficacy in reducing inflammation and depression in people with HIV

8 weeks
Regular visits for supervised exercise sessions

Follow-up

Participants are monitored for safety and effectiveness after the exercise intervention

4 weeks

Treatment Details

Interventions

  • Supervised Treadmill Intervention
Trial Overview The STRIDE Pilot Study is testing whether supervised treadmill exercises can help reduce inflammation and alleviate symptoms of depression in people living with HIV. The study will provide upfront advice on walking as part of the intervention.
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Intervention groupExperimental Treatment1 Intervention
participants randomized to intervention group
Group II: controlPlacebo Group1 Intervention
participants randomized to control group

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Minnesota

Lead Sponsor

Trials
1,459
Recruited
1,623,000+

Findings from Research

A 12-week supervised aerobic exercise program significantly reduced self-reported depressive symptoms in 60 HIV-infected adults compared to control participants.
The study found strong correlations between different scales measuring depressive symptoms, supporting the validity of these assessment tools in this population.
Aerobic exercise training for depressive symptom management in adults living with HIV infection.Neidig, JL., Smith, BA., Brashers, DE.[2022]
In a 24-week exercise training program involving 25 individuals with HIV, only 6 completed the program, but all showed significant improvements in cardiovascular fitness, including increased VO2max and decreased heart rate during submaximal exercise.
The study suggests that while exercise training is feasible and beneficial for some HIV-infected individuals, mental health factors like depression and anxiety may impact CD4 counts, indicating a need for holistic approaches in treatment.
Supervised exercise training improves cardiopulmonary fitness in HIV-infected persons.MacArthur, RD., Levine, SD., Birk, TJ.[2022]
In a study of 165 adults with unipolar depression, strength training significantly improved work capacity, reducing absenteeism by 12.1% compared to relaxation training, while aerobic training showed no significant effect on work absence.
Despite improvements in physical strength and aerobic capacity, neither strength nor aerobic training led to significant reductions in depression severity as measured by the Hamilton Rating Scale for Depression (HAM-D(17)) at 4 or 12 months.
The DEMO trial: a randomized, parallel-group, observer-blinded clinical trial of strength versus aerobic versus relaxation training for patients with mild to moderate depression.Krogh, J., Saltin, B., Gluud, C., et al.[2019]

References

Aerobic exercise training for depressive symptom management in adults living with HIV infection. [2022]
Supervised exercise training improves cardiopulmonary fitness in HIV-infected persons. [2022]
The DEMO trial: a randomized, parallel-group, observer-blinded clinical trial of strength versus aerobic versus relaxation training for patients with mild to moderate depression. [2019]
The effect of exercise in clinically depressed adults: systematic review and meta-analysis of randomized controlled trials. [2023]
Effects of exercise on depression and anxiety in persons living with HIV: A meta-analysis. [2020]
6.United Arab Emiratespubmed.ncbi.nlm.nih.gov
HIV Patient Characteristics that Affect Adherence to Exercise Programmes: An Observational Study. [2021]
Physical activity and exercise to improve cardiovascular health for adults living with HIV. [2020]
Effects of a Combined Exercise Training Program on Health Indicators and Quality of Life of People Living with HIV: A Randomized Clinical Trial. [2020]
The effectiveness of a community-based exercise program on depression symptoms among people living with HIV. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security